{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T06:10:47Z","timestamp":1759558247860,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.ejogrb.2014.06.007","type":"journal-article","created":{"date-parts":[[2014,6,23]],"date-time":"2014-06-23T20:31:38Z","timestamp":1403555498000},"page":"153-156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Naltrexone as a diagnostic tool to distinguish between hyperandrogenemic and hypothalamic ovarian failure in females with congenital adrenal hyperplasia due to 21-hydroxylase-deficiency (CAH)"],"prefix":"10.1016","volume":"180","author":[{"given":"B.","family":"B\u00f6ttcher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.G.","family":"D\u00f6rr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Wildt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"June (3)","key":"10.1016\/j.ejogrb.2014.06.007_bib0005","first-page":"245","article-title":"Congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"3","author":"White","year":"2000","journal-title":"Endocr Rev"},{"issue":"January (4)","key":"10.1016\/j.ejogrb.2014.06.007_bib0010","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1056\/NEJM198701223160402","article-title":"Fertility rates in female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"316","author":"Mulaikal","year":"1987","journal-title":"N Engl J Med"},{"issue":"October (4)","key":"10.1016\/j.ejogrb.2014.06.007_bib0015","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0015-0282(03)01006-9","article-title":"Monitoring of menstrual cycles, ovulation, and adrenal suppression by saliva sampling in female patients with 21-hydroxylase deficiency","volume":"80","author":"Stikkelbroeck","year":"2003","journal-title":"Fertil Steril"},{"issue":"July (7)","key":"10.1016\/j.ejogrb.2014.06.007_bib0020","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/humrep\/den118","article-title":"Fertility and pregnancy outcome in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"23","author":"Hagenfeldt","year":"2008","journal-title":"Hum Reprod"},{"issue":"May (5)","key":"10.1016\/j.ejogrb.2014.06.007_bib0025","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.fertnstert.2003.10.024","article-title":"Pregnancies in patients with congenital adrenal hyperplasia with complete or almost complete impairment of 21-hydroxylase activity","volume":"81","author":"Hoepffner","year":"2004","journal-title":"Fertil Steril"},{"issue":"June (6)","key":"10.1016\/j.ejogrb.2014.06.007_bib0030","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/j.1365-2265.2009.03563.x","article-title":"Reassessing fecundity in women with classical congenital adrenal hyperplasia (CAH): normal pregnancy rate but reduced fertility rate","volume":"70","author":"Caster\u00e0s","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.ejogrb.2014.06.007_bib0035","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000327794","article-title":"Health problems in congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"76","author":"Reisch","year":"2011","journal-title":"Horm Res Paediatr"},{"issue":"April (4)","key":"10.1016\/j.ejogrb.2014.06.007_bib0040","first-page":"933","article-title":"Subnormal androgen and elevated progesterone levels in women treated for congenital virilizing 21-hydroxylase deficiency","volume":"76","author":"Helleday","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"issue":"November (Suppl. 2)","key":"10.1016\/j.ejogrb.2014.06.007_bib0045","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/humrep\/8.suppl_2.168","article-title":"Opiate antagonist treatment of ovarian failure","volume":"8","author":"Wildt","year":"1993","journal-title":"Hum Reprod"},{"issue":"March (3)","key":"10.1016\/j.ejogrb.2014.06.007_bib0050","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/oxfordjournals.humrep.a138050","article-title":"Treatment with naltrexone in hypothalamic ovarian failure: induction of ovulation and pregnancy","volume":"8","author":"Wildt","year":"1993","journal-title":"Hum Reprod"},{"issue":"November (5)","key":"10.1016\/j.ejogrb.2014.06.007_bib0055","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0015-0282(16)57908-4","article-title":"Naltrexone treatment restores menstrual cycles in patients with weight loss-related amenorrhea","volume":"64","author":"Genazzani","year":"1995","journal-title":"Fertil Steril"},{"issue":"September (1)","key":"10.1016\/j.ejogrb.2014.06.007_bib0060","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1530\/jrf.0.0690397","article-title":"Induction of ovulation with chronic intermittent (pulsatile) administration of Gn-RH in women with hypothalamic amenorrhoea","volume":"69","author":"Leyendecker","year":"1983","journal-title":"J Reprod Fertil"},{"issue":"November (11)","key":"10.1016\/j.ejogrb.2014.06.007_bib0065","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1093\/oxfordjournals.humrep.a135809","article-title":"Naltrexone administration modulates the neuroendocrine control of luteinizing hormone secretion in hypothalamic amenorrhoea","volume":"10","author":"Genazzani","year":"1995","journal-title":"Hum Reprod"},{"issue":"September (3)","key":"10.1016\/j.ejogrb.2014.06.007_bib0070","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-2265.1995.tb02034.x","article-title":"Menstrual disturbance and hypersecretion of progesterone in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"43","author":"Holmes-Walker","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"November (5)","key":"10.1016\/j.ejogrb.2014.06.007_bib0075","first-page":"1328","article-title":"Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women","volume":"79","author":"Barnes","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"issue":"October (10)","key":"10.1016\/j.ejogrb.2014.06.007_bib0080","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1651-2227.1996.tb18223.x","article-title":"Elevation of serum luteinizing hormone levels during hydrocortisone treatment in infant girls with 21-hydroxylase deficiency","volume":"85","author":"Belgorosky","year":"1996","journal-title":"Acta Paediatr"},{"issue":"October (4)","key":"10.1016\/j.ejogrb.2014.06.007_bib0085","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1530\/EJE-12-0454","article-title":"Influence of hormonal control on LH pulsatility and secretion in women with classical congenital adrenal hyperplasia","volume":"167","author":"Bachelot","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"Feburary (2)","key":"10.1016\/j.ejogrb.2014.06.007_bib0090","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1210\/jcem-58-2-378","article-title":"Progesterone modulation of pulsatile luteinizing hormone secretion in normal women","volume":"58","author":"Soules","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"issue":"July (7)","key":"10.1016\/j.ejogrb.2014.06.007_bib0095","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/BF03343880","article-title":"Naltrexone effect on pulsatile GnRH therapy for ovulation induction in polycystic ovary syndrome: a pilot prospective study","volume":"24","author":"Fulghesu","year":"2001","journal-title":"J Endocrinol Invest"},{"issue":"August (8)","key":"10.1016\/j.ejogrb.2014.06.007_bib0100","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1093\/humrep\/12.8.1720","article-title":"Successful induction of ovulation in normogonadotrophic clomiphene resistant anovulatory women by combined naltrexone and clomiphene citrate treatment","volume":"12","author":"Roozenburg","year":"1997","journal-title":"Hum Reprod"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211514003364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211514003364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:33:25Z","timestamp":1759556005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211514003364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":20,"alternative-id":["S0301211514003364"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2014.06.007","relation":{},"ISSN":["0301-2115"],"issn-type":[{"type":"print","value":"0301-2115"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Naltrexone as a diagnostic tool to distinguish between hyperandrogenemic and hypothalamic ovarian failure in females with congenital adrenal hyperplasia due to 21-hydroxylase-deficiency (CAH)","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2014.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}